Bank of Montreal’s Indaptus Therapeutics INDP Stock Holding History

Bank of Montreal’s Portfolio INDP Stock Details INDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9	Closed	-$4K	–	4259
2021 Q1	$4K	Buy	+9	New	+$4.72K	﹤0.01%	4733
2019 Q3	–	Sell	-1	Closed	-$10K	–	4848
2019 Q2	$10K	Buy	+1	New	+$12.6K	﹤0.01%	4520

Other funds holding INDP

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of Montreal's INDP Position: Q2 2021 in Review

Bank of Montreal sold out of Indaptus Therapeutics (INDP) in Q2 2021, closing a stake of 9 shares — an estimated $4K sold.

Bank of Montreal first reported a position in INDP in Q2 2019 and held it in 2 quarters. The position peaked at $10K in Q2 2019. 10 funds tracked by Wall St. Rank hold INDP as of Q2 2021.

Bank of Montreal reported no remaining Indaptus Therapeutics position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 9 Indaptus Therapeutics shares in Q2 2021, an estimated $4K.
Bank of Montreal first reported a position in Indaptus Therapeutics in Q2 2019 and held it in 2 quarters.
Bank of Montreal's Indaptus Therapeutics position peaked at $10K in Q2 2019.
10 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.